| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 42.5 Billion |
| 2025 Market Size | USD 45.3 Billion |
| 2032 Forecast | USD 75.8 Billion |
| Growth Rate (CAGR) | 7.6% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Nature of the Market | Fragmented |
|
Explore the market potential with our data-driven report
The global biomaterials market size was valued at USD 42.5 billion in 2024, and it is expected to reach USD 75.8 billion by 2032, advancing at a growth rate of 7.6% during 2025–2032. The market growth has been spurred by technological advancements, the growing incidence of musculoskeletal and chronic skeletal medical conditions, and rising government supports including grants and funds to boost the production of novel biomaterials. Moreover, the surging urbanization and expanding number of fitness centers and health clubs boost the demand for biomaterials.
Biomaterials are widely used in orthopedics due to their mechanical and biological stability, appropriate design and manufacturability, corrosion resistant, high tensile strengths, and high wear resistance. Biomaterials are used for manufacturing implants for the stabilization and fixation of bones, joint replacements, non-conventional modular tumor implants, and spine implants. The orthopedics sector is growing significantly, due to the growing implantable device requirement and an increasing number of hip and knee replacements.
Moreover, in dentistry, they are used to restore damaged, decayed, or fractured teeth. The progress in the application is significant, due to the increasing awareness for oral care, rising disposable income, and high success rate of dental implants. Metals, ceramics, composites, and polymers are synthetic dental materials.
The increasing research and development activities are the key drivers for the growth of the market. Current research subjects in dental biomaterials are fractography of brittle materials including restorative composites, metal-ceramics, and ceramics, resin wear composite wears polymerization shrinkage, effective light curing of polymerization of resin-based composite materials, and adhesion of resin-based composites to restorative dental materials.
Being a multi-factor physiological process, wound healing is a complex phenomenon prone to various abnormalities. Several self-healing biomaterials are being developed for wound healing. Gel materials, composites, films, and membranes are widely used for wound healing. Hydrogel dressings provide a barrier between the wound and the external environment, thereby protecting against infections. Biomaterials for internal wounds damage or repel microbes and other infectious agents. These materials are hydrophilic and porous, thus absorbing exuded liquids. These materials also help fill the void in damaged organs or tissues.
The cardiovascular category dominates the market with 25% share in 2024. The rising burden of cardiovascular diseases would result in higher death rates and additional economic costs. These diseases are the leading cause of premature death around the world. Biomaterials are utilized to manufacture several devices or implants for the treatment or diagnosis of this problem. Extracorporeal pump oxygenators, catheters, stents, heart-assist devices, prosthetic heart valves, and vascular grafts are made up of different types of biomaterials. Moreover, as per a study, over 209 million people around the world have heart valve diseases. Many of whom are implanted with artificial heart valves, which are made from bovine (cow) or procine (pig) tissue.
The plastic surgeries category is expected to record the fastest growth in the biomaterials market during the forecast period. Biomaterials are being used for reconstructive as well as cosmetic purposes in plastic surgeries. The category is expected to grow as different vendors are investing huge capital to develop safe and reliable products for use in plastic surgeries. Breast implants are one of the major applications of biomaterials in these surgeries.
With the rapid increase of applications of plastic surgeries, several new and advanced products for these surgeries are available globally. Soft tissue fillers, acellular dermal matrices, biomaterials for craniofacial surgeries, and bioengineered skins are gaining immense popularity.
These applications are covered:
The metallic category accounted for the largest market share in 2024, and it is projected to maintain its dominance in the coming years. These materials have been used substantially in biomedical devices and components, such as hard tissue replacements, and cardiac and cardiovascular stents, owing to their desirable mechanical properties and biocompatibility. To improve the biological properties to meet the clinical requirements, chemical surface modification is regularly performed on metallic biomaterials.
Materials used for biomedical applications are 316L stainless steel, titanium-based alloys (Ti-6Al-4V), cobalt-chromium alloys (CoCrMo), and others (such as tantalum, gold, dental amalgams, and specialty metals). Titanium has become one of the most promising engineering materials and the interest in the application of titanium alloys to mechanical and tribological components is proliferating rapidly in the biomedical field.
The polymer category will have the highest CAGR during the forecast period, of 15%, owing to their lightweight, higher flexibility, biochemical resistance property, availability in various compositions, and ease of manufacturing products with desired specifications.
A large number of polymer materials are used as biomaterials for medical implant systems. Some of these are polyesters, acrylics, polyethylene, polyamides, polyurethane, and polysiloxanes. Due to the several advantages of these polymers, they are increasingly being used in various applications such as artificial heart, liver, kidney, pancreas, bone cement, bladder, catheters, contact lenses, external and internal ear repairs, cornea and eye-lens replacements, cardiac assist devices, heart valves, joint replacements, implantable pumps, pacemaker, soft-tissue replacement, encapsulations, artificial skin, artificial blood vessels, and sutures. Plastics can easily be shaped into sticks, thick liquids, and gels to be used for 3D printing applications.
These types have been studied:
Drive strategic growth with comprehensive market analysis
In 2024, North America accounted for the highest revenue in the biomaterials market. This is ascribed to booming healthcare expenditure, rising government support, and increasing awareness of implantable medical devices. Moreover, the presence of a large number of market players, the increasing need for implantable devices, and the surging number of knee and hip replacements are also fueling the demand for biomaterials in the U.S. Further, women are becoming more interested in plastic surgeries, including liposuction, facelifts, breast augmentation, tummy tucks, and breast lifts, drives the regional market.
As per the American Society of Plastic Surgeons, 304,181 breast augmentation procedures were conducted in the U.S. in 2023, compared to 298,568 in 2022. The count of procedures stood at 7,338 in 2022 and 7,748 in 2023 for butt lifts, 1,164 in 2022 and 1,234 in 2023 for butt implants, and 44,503 in 2022 and 47,307 in 2023 for rhinoplasties. The escalating number of plastic surgery procedures drives the need and production of biomaterials.
In addition, Europe holds a significant share of the market due to the constant product innovations and elevating demand from the medical industry. The most eminent end use of biomaterials is orthopedics, owing to the rising number of surgeries in the region. Germany has a substantial share in the regional market, due to the mushrooming need for minimally invasive surgeries, high patient awareness levels, and the presence of advanced healthcare infrastructure for joint replacement surgery in the country.
APAC is the fastest-growing region in the market, with a CAGR of 15%. The major reasons for the fastest growth of the market in the region includes improving healthcare infrastructure, increasing prevalence of chronic diseases, technological advancements and increasing geriatric population. As per the WHO, 28% of China’s population will be aged 60 or more by 2040. Similarly, the population in this age group in India is set to rise from 153 million in 2023 to 347 million by 2050. Moreover, Japan and South Korea are the two oldest countries in the world, with 37.5% of the population of the former and 39.4% of the latter expected to be in the age group of 65 and above by 2050.
Additionally, 25 million people in China suffer from diseases involve one of the four heart valves, which drives the demand for artificial valves. Moreover, over 61 million people in India suffer from osteoporosis, which puts people at a high risk for fractures. This drives the volume of partial/total hip and joint replacement surgeries, in which metal rods and screws and hydroxyapatite bone fillers are used. As per the WHO, Southeast Asia accounts for over 900 million untreated cases of severe periodontal diseases, dental caries, and edentulism. This hints at a massive market opportunity in the near future as dental cements and artificial tooth crowns will be widely required for these people.
Moreover, the improving healthcare infrastructure, high growth in healthcare industry and increasing awareness among healthcare providers for the usage of advanced biomaterials is fueling the growth of the Asia-Pacific biomaterials market.
These regions and countries have been analyzed:
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages